Breaking News, Collaborations & Alliances

BioMed X, AbbVie Launch New Research Project Focused on Anhedonia

Researchers are invited to submit proposals for innovative research projects aimed at uncovering the entangled microcircuits and molecular targets disrupted in anhedonia.

Author Image

By: Charlie Sternberg

Associate Editor

BioMed X, an external innovation hub for pharma, has launched a new collaborative research project with AbbVie, hosted at the BioMed X Institute in New Haven, Connecticut. The topic of the new research project in the field of neuroscience is the development of “Circuit-Based Model Systems of Anhedonia.” Anhedonia, the diminished ability to experience pleasure, remains one of the most challenging and poorly treated symptoms of depression, as well as several other psychiatric conditions. The...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics